LADENBURG THALMANN FINANCIAL SERVICES INC. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,0000.0%840.0%0.00%
Q4 2015$1,000
-66.7%
84
-78.2%
0.00%
Q3 2015$3,000
-25.0%
385
-11.1%
0.00%
Q2 2015$4,000433
+1961.9%
0.00%
Q1 2015$0210.0%0.00%
Q4 2014$021
-19.2%
0.00%
Q3 2013$0260.0%0.00%
Q2 2013$0260.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders